Galapagos NV - American Depositary Shares (GLPG)

32.48
-0.63 (-1.90%)
NASDAQ · Last Trade: Jan 13th, 9:52 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Adaptimmune and Galapagos Sign Clinical Collaboration Agreement with an Option to Exclusively License Adaptimmune's TCR T-cell Therapy Candidate, uza-cel, in Head & Neck Cancer and Potential Future Solid Tumor Indications
Adaptimmune and Galapagos to conduct clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel (next-generation MAGE-A4 TCR T-cell...
Via Newsfile · May 30, 2024
Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline
- First participant dosed in Phase 1/2 PROSPER trial of FMC-376 in KRASG12C Cancers
By Frontier Medicines · Via GlobeNewswire · February 22, 2024